SYM Financial Corp
REGN icon

SYM Financial Corp’s Regeneron Pharmaceuticals REGN Stock Holding History

SYM Financial Corp’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$544K Buy
718
+144
+25% +$109K 0.04% 152
2026
Q2 		$358K Sell
574
-21
-4% -$14.3K 0.03% 216
2026
Q1 		$460K Buy
595
+13
+2% +$10K 0.05% 144
2025
Q4 		$449K Buy
582
+140
+32% +$95.1K 0.05% 141
2025
Q3 		$249K Buy
+442
New +$250K 0.03% 258

Other funds holding REGN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

SYM Financial Corp's REGN Position: Q3 2026 in Review

SYM Financial Corp increased its Regeneron Pharmaceuticals (REGN) stake by 25% in Q3 2026, buying an estimated $109K and bringing the position to 718 shares worth $544K. The position accounts for 0.04% of the portfolio, ranked #152.

SYM Financial Corp first reported a position in REGN in Q3 2025 and has held it in 5 quarters since. 755 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • SYM Financial Corp held 718 shares of Regeneron Pharmaceuticals worth $544K as of Q3 2026.
  • SYM Financial Corp bought 144 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $109K.
  • Regeneron Pharmaceuticals made up 0.04% of SYM Financial Corp's portfolio in Q3 2026, its #152 holding.
  • SYM Financial Corp first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • 755 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on SYM Financial Corp's 13F filing for Q3 2026, filed 26 Oct 2026.